Physician profile
Priya Thakker
NPI 1538359633
$595.60
in general payments reported to CMS, 2019-2025
12 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.80 · 2022: $29.81 · 2023: $95.44 · 2024: $263 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $130.84 | 2023-2025 | |
| Abbvie INC. | $111.06 | 2021-2025 | Skyrizi |
| Lilly USA, LLC | $94.83 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $58.27 | 2022-2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $56.53 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.48 | 2021-2024 | Cabtreo |
| Arcutis Biotherapeutics, INC. | $28.98 | 2023-2024 | Zoryve |
| Janssen Biotech, INC. | $18.07 | 2025 | Tremfya |
| Incyte Corporation | $17.95 | 2024 | Opzelura |
| Galderma Laboratories, L.P. | $16.57 | 2024 | |
| Verrica Pharmaceuticals INC. | $15.68 | 2024 | Ycanth |
| Genzyme Corporation | $15.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Thakker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.